Cargando…
Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen
Pancreatic cancer is the fourth largest cause of cancer deaths in the Unites States and the prognosis is grim with <5% survival chances upon diagnosis. The objective of this study was to assess the combined chemopreventive effect of solid lipid nanoparticle (SLN) encapsulated drugs aspirin (ASP),...
Autores principales: | SUTARIA, DHRUVITKUMAR, GRANDHI, BALAGANGADHAR KARTHIK, THAKKAR, ARVIND, WANG, JEFFREY, PRABHU, SUNIL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583628/ https://www.ncbi.nlm.nih.gov/pubmed/23007664 http://dx.doi.org/10.3892/ijo.2012.1636 |
Ejemplares similares
-
The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer
por: THAKKAR, ARVIND, et al.
Publicado: (2013) -
Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice
por: Thakkar, Arvind, et al.
Publicado: (2016) -
Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles
por: Thakkar, Arvind, et al.
Publicado: (2015) -
Chemopreventive activity of sulforaphane
por: Jiang, Xin, et al.
Publicado: (2018) -
Sulforaphane (SFN): An Isothiocyanate in a Cancer Chemoprevention Paradigm
por: Ullah, Mohammad Fahad
Publicado: (2015)